TVTX TRAVERE THERAPEUTICS INC Earnings Reports 8-K Filing 2024 - Q3 Earnings Report TRAVERE THERAPEUTICS INC reported its financial results for the third quarter of 2023, showing a revenue of $15 million and a net loss of $10 million.Get access to all SEC 8-K filings of the TRAVERE THERAPEUTICS INC